Department of Clinical Pathology, Mansoura University, Egypt.
Endocr Pract. 2012 May-Jun;18(3):376-81. doi: 10.4158/EP11130.OR.
To investigate ghrelin and resistin concentrations in patients with hyperthyroidism before and after restoration to a euthyroid state and to correlate the 2 peptides with anthropometric and insulin resistance parameters.
The study included hyperthyroid patients and euthyroid healthy participants as a control group. Hyperthyroid patients were evaluated at the start of the study and after normalization of thyroid function with appropriate antithyroid drugs. Anthropometric parameters, insulin resistance parameters (fasting blood glucose, fasting insulin, and homeostasis model assessment-insulin resistance), thyroid function tests, and measurement of ghrelin and resistin were assessed in patients and control participants.
The study included 40 hyperthyroid patients (32 women and 8 men, aged 26-42 years) and 30 euthyroid healthy participants (20 women and 10 men, aged 25-43 years) as a control group. In hyperthyroid patients, serum resistin levels and insulin resistance parameters were higher and plasma ghrelin levels were lower than in control participants (P<.001), and all normalized after treatment. Ghrelin levels were correlated only with insulin resistance parameters, but no correlations with any anthropometric or laboratory data were found. Resistin levels did not correlate with any clinical or laboratory data of hyperthyroid patients.
In hyperthyroid patients, resistin was increased and ghrelin was decreased, they were not related to anthropometric parameters, and they normalized after treatment of hyperthyroidism.
研究甲状腺功能亢进症患者在恢复甲状腺功能正常前后的生长激素释放肽和抵抗素浓度,并将这两种肽与人体测量学和胰岛素抵抗参数相关联。
本研究纳入了甲状腺功能亢进症患者和甲状腺功能正常的健康参与者作为对照组。甲状腺功能亢进症患者在研究开始时进行评估,并在适当的抗甲状腺药物使甲状腺功能正常化后进行评估。评估患者和对照组参与者的人体测量学参数、胰岛素抵抗参数(空腹血糖、空腹胰岛素和稳态模型评估-胰岛素抵抗)、甲状腺功能检查以及生长激素释放肽和抵抗素的测量。
本研究纳入了 40 例甲状腺功能亢进症患者(32 名女性和 8 名男性,年龄 26-42 岁)和 30 例甲状腺功能正常的健康参与者(20 名女性和 10 名男性,年龄 25-43 岁)作为对照组。甲状腺功能亢进症患者的血清抵抗素水平和胰岛素抵抗参数较高,血浆生长激素释放肽水平较低,与对照组参与者相比(P<.001),且所有这些参数在治疗后均恢复正常。生长激素释放肽水平仅与胰岛素抵抗参数相关,但与任何人体测量学或实验室数据均无相关性。抵抗素水平与甲状腺功能亢进症患者的任何临床或实验室数据均无相关性。
在甲状腺功能亢进症患者中,抵抗素增加,生长激素释放肽减少,它们与人体测量学参数无关,且在治疗甲状腺功能亢进症后恢复正常。